Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Algisys
AddedFeb 15, 2024
UpdatedJun 18, 2026
Algisys

Algisys

Series A

AlgiSys, a biotech firm, produces algal oils and additives, committed to ESG principles.

HQ
Cleveland, OH, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

AlgiSys, founded with a mission to provide sustainable solutions for omega ingredients, is a biotechnology company focused on producing algal oils and additives. The firm is committed to Environmental, Social, and Corporate Governance (ESG) principles, aiming to preserve natural resources while operating transparently. AlgiSys commercializes patented algal technologies that can replace fish and krill oil as primary sources of EPA Omega-3, catering to markets including human health, pet nutrition, animal feed, and aquaculture.

Notable affiliated individuals and investors in AlgiSys include experts in biotechnology and sustainability sectors. The company has achieved significant milestones in developing and patenting its algal technologies. Its impact is profound, offering a sustainable alternative to traditional omega-3 sources, thereby contributing to environmental conservation and reducing reliance on overfished marine resources. AlgiSys's innovations support healthier ecosystems and promote responsible resource management globally.

Algisys - Quick Facts

When was Algisys founded?

Algisys was founded in 2009.

Where is Algisys' headquarters located?

Algisys' headquarters is located in Cleveland, OH, US.

When was Algisys' last funding round?

Algisys' most recent funding round was for $6.2M (USD) in August 2013.

How much has Algisys raised to-date?

As of Aug 14, 2013, Algisys has raised a total of $8.9M (USD).

How many employees does Algisys have?

Algisys has 7 employees as of Feb 5, 2024.

Algisys - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Additives
  • Algal Oils
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 337000Furniture and Related Product Manufacturing
  • 337100Household and Institutional Furniture and Kitchen Cabinet Manufacturing
  • 337120Household and Institutional Furniture Manufacturing
  • 337127Institutional Furniture Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
SIC
  • 2000Food And Kindred Products
  • 2070Fats And Oils
  • 2079Shortening, Table Oils, Margarine, And Other Edible Fats And Oils
  • 3990Miscellaneous Manufacturing Industries
  • 3999Manufacturing Industries, Not Elsewhere Classified
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified